Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Propranolol for Hyperadrenergic Activity in Neurologic Injury
NCT01343329Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jul 2011
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol in dysautonomia, sponsored by Johns Hopkins University. Planned start Jul 2011; status: withdrawn.
02
Drugs
esmolol
03
Conditions
dysautonomia
Beyond the preview
Go deeper on NCT01343329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343329.